ICM
CLB icon

Islay Capital Management’s Core Laboratories CLB Stock Holding History

Islay Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$2.33K – 225
2023
Q2 		$2.33K Hold
100
– – ﹤0.01% 203
2023
Q1 		$2.21K Hold
100
– – ﹤0.01% 207
2022
Q4 		$2.03K Buy
+100
New +$1.94K ﹤0.01% 227
2020
Q1 		– Sell
-800
Closed -$30K – 262
2019
Q4 		$30K Buy
+800
New +$35.9K 0.03% 185

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Islay Capital Management's CLB Position: Q3 2023 in Review

Islay Capital Management sold out of Core Laboratories (CLB) in Q3 2023, closing a stake of 100 shares — an estimated $2.33K sold.

Islay Capital Management first reported a position in CLB in Q4 2019 and held it in 4 quarters. The position peaked at $30K in Q4 2019. 178 funds tracked by Wall St. Rank hold CLB as of Q3 2023.

  • Islay Capital Management reported no remaining Core Laboratories position as of Q3 2023 after selling out during the quarter.
  • Islay Capital Management sold 100 Core Laboratories shares in Q3 2023, an estimated $2.33K.
  • Islay Capital Management first reported a position in Core Laboratories in Q4 2019 and held it in 4 quarters.
  • Islay Capital Management's Core Laboratories position peaked at $30K in Q4 2019.
  • 178 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2023.

Based on Islay Capital Management's 13F filing for Q3 2023, filed 2 Nov 2023.